Amrize (AMRZ) EBITDA (2024 - 2026)

Amrize has disclosed EBITDA across 3 years of filings, most recently posting $711.0 million for Q2 2026.

• In Q2 2026, EBITDA rose 8.22% year-over-year to $711.0 million; the TTM figure through Jun 2026 stood at $1.9 billion (down 6.94% YoY), while the FY2025 annual figure was $1.9 billion, down 13.17% from the prior year.
• EBITDA came in at $711.0 million for Q2 2026 at Amrize, up from -$72.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $844.0 million in Q3 2024 to a low of -$72.0 million in Q1 2026.
• Average EBITDA over 3 years is $519.9 million, with a median of $657.0 million recorded in 2025.
• The largest YoY upside for EBITDA was 8.22% in 2026 against a maximum downside of 1340.0% in 2026.
• Over 3 years, EBITDA stood at $537.0 million in 2024, then declined by 11.55% to $475.0 million in 2025, then surged by 49.68% to $711.0 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $711.0 million in Q2 2026, -$72.0 million in Q1 2026, and $475.0 million in Q4 2025.